NCT03497013View on ClinicalTrials.gov

Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

August 11, 2020

Study Completion Date

August 11, 2020

Conditions
Tardive Dyskinesia
Interventions
DEVICE

Active tDCS

All patients received 2-mA anodal left/cathodal right prefrontal tDCS treatment (fifteen 30-minutes sessions: Monday to Friday once daily, every other week to do a group of treatment).

DEVICE

Sham tDCS

For sham stimulation, the device was set to turn off after 30 seconds(study model).

Trial Locations (2)

215137

Suzhou Psychiatric Hospital, Suzhou

215237

Suzhou, Suzhou

All Listed Sponsors
lead

Suzhou Psychiatric Hospital

OTHER

NCT03497013 - Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia | Biotech Hunter | Biotech Hunter